NO824242L - Nytt antigen for utforskning av toxoplasmisk immunitet samt fremstilling derav - Google Patents
Nytt antigen for utforskning av toxoplasmisk immunitet samt fremstilling deravInfo
- Publication number
- NO824242L NO824242L NO824242A NO824242A NO824242L NO 824242 L NO824242 L NO 824242L NO 824242 A NO824242 A NO 824242A NO 824242 A NO824242 A NO 824242A NO 824242 L NO824242 L NO 824242L
- Authority
- NO
- Norway
- Prior art keywords
- antigen
- toxoplasmic
- cells
- toxoplasma
- carried out
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title claims description 49
- 102000036639 antigens Human genes 0.000 title claims description 44
- 108091007433 antigens Proteins 0.000 title claims description 44
- 230000036039 immunity Effects 0.000 title claims description 11
- 238000004519 manufacturing process Methods 0.000 title claims description 4
- 210000004027 cell Anatomy 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 12
- 241000223996 Toxoplasma Species 0.000 claims description 11
- 210000002966 serum Anatomy 0.000 claims description 11
- 244000309466 calf Species 0.000 claims description 7
- 230000002779 inactivation Effects 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 229960004279 formaldehyde Drugs 0.000 claims description 5
- 241000700198 Cavia Species 0.000 claims description 4
- 241000223997 Toxoplasma gondii Species 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 235000019256 formaldehyde Nutrition 0.000 claims description 4
- 230000001936 parietal effect Effects 0.000 claims description 4
- 210000001840 diploid cell Anatomy 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 239000002245 particle Substances 0.000 claims description 3
- 230000003612 virological effect Effects 0.000 claims description 3
- 206010020751 Hypersensitivity Diseases 0.000 claims description 2
- 208000026935 allergic disease Diseases 0.000 claims description 2
- 238000000502 dialysis Methods 0.000 claims description 2
- 230000009610 hypersensitivity Effects 0.000 claims description 2
- 238000011081 inoculation Methods 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims 2
- 210000004102 animal cell Anatomy 0.000 claims 1
- 238000002360 preparation method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 241000282693 Cercopithecidae Species 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000009589 serological test Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 241001214257 Mene Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 231100001221 nontumorigenic Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000011236 particulate material Substances 0.000 description 1
- 229960001539 poliomyelitis vaccine Drugs 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8123565A FR2518407A1 (fr) | 1981-12-17 | 1981-12-17 | Nouvel antigene pour la recherche de l'immunite toxoplasmique et son procede de preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO824242L true NO824242L (no) | 1983-06-20 |
Family
ID=9265121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO824242A NO824242L (no) | 1981-12-17 | 1982-12-16 | Nytt antigen for utforskning av toxoplasmisk immunitet samt fremstilling derav |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0082745B1 (fi) |
| JP (1) | JPS58126814A (fi) |
| AR (1) | AR228806A1 (fi) |
| AT (1) | ATE14274T1 (fi) |
| AU (1) | AU554541B2 (fi) |
| CA (1) | CA1206904A (fi) |
| DE (1) | DE3264792D1 (fi) |
| ES (1) | ES518127A0 (fi) |
| FI (1) | FI71165C (fi) |
| FR (1) | FR2518407A1 (fi) |
| NO (1) | NO824242L (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2564731B1 (fr) * | 1984-05-28 | 1986-10-10 | Ambroise Thomas Pierre | Nouvelles fractions exo-antigeniques toxoplasmiques, leur procede de preparation et leur application a la recherche de l'immunite toxoplasmique chez l'homme par tests cutanes |
| FR2618680B1 (fr) * | 1987-07-31 | 1990-05-11 | Pasteur Institut | Antigenes d'excretion-secretion specifiques de toxoplasma gondii, leurs produits d'expression, leur procede d'obtention et leurs applications diagnostiques et prophylactiques |
| FR2625099B1 (fr) * | 1987-12-24 | 1991-06-14 | Transgene Sa | Proteines et leur procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees et compositions pharmaceutiques utiles dans la prevention de la toxoplasmose |
| SI1856159T1 (sl) | 2005-03-08 | 2010-08-31 | Sigma Tau Ind Farmaceuti | Kimerni rekombinantni antigeni toksoplazme gondii |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5444016A (en) * | 1977-09-13 | 1979-04-07 | Nippon Touketsu Kansou Kenkiyu | Latex coagulation and reaction reagent for detecting toxoplasma antibody and production thereof |
| FR2482980A1 (fr) * | 1980-05-20 | 1981-11-27 | Biomerieux Sa | Procede d'obtention de preparations de toxoplasmes pour le diagnostic de la toxoplasmose, et preparations ainsi obtenues |
-
1981
- 1981-12-17 FR FR8123565A patent/FR2518407A1/fr active Granted
-
1982
- 1982-12-02 AT AT82402197T patent/ATE14274T1/de active
- 1982-12-02 DE DE8282402197T patent/DE3264792D1/de not_active Expired
- 1982-12-02 EP EP82402197A patent/EP0082745B1/fr not_active Expired
- 1982-12-10 AU AU91404/82A patent/AU554541B2/en not_active Ceased
- 1982-12-10 AR AR291563A patent/AR228806A1/es active
- 1982-12-13 ES ES518127A patent/ES518127A0/es active Granted
- 1982-12-14 JP JP57217930A patent/JPS58126814A/ja active Pending
- 1982-12-14 FI FI824280A patent/FI71165C/fi not_active IP Right Cessation
- 1982-12-16 NO NO824242A patent/NO824242L/no unknown
- 1982-12-16 CA CA000417915A patent/CA1206904A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0082745A1 (fr) | 1983-06-29 |
| ES8308485A1 (es) | 1983-09-01 |
| JPS58126814A (ja) | 1983-07-28 |
| ES518127A0 (es) | 1983-09-01 |
| FI71165C (fi) | 1986-11-24 |
| FI71165B (fi) | 1986-08-14 |
| FR2518407A1 (fr) | 1983-06-24 |
| FI824280A0 (fi) | 1982-12-14 |
| AR228806A1 (es) | 1983-04-15 |
| FI824280L (fi) | 1983-06-18 |
| AU9140482A (en) | 1983-06-23 |
| AU554541B2 (en) | 1986-08-28 |
| ATE14274T1 (de) | 1985-08-15 |
| DE3264792D1 (en) | 1985-08-22 |
| CA1206904A (en) | 1986-07-02 |
| EP0082745B1 (fr) | 1985-07-17 |
| FR2518407B1 (fi) | 1984-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schaffer et al. | Purification and properties of poliovirus | |
| RU2446824C2 (ru) | Вакцина против гриппа и способ ее получения | |
| Molander et al. | Isolation and characterization of viruses from fetal calf serum | |
| Weiss et al. | Cytomegaloviruses. Rinderpest virus. Lumpy skin disease virus | |
| NO824242L (no) | Nytt antigen for utforskning av toxoplasmisk immunitet samt fremstilling derav | |
| Jawetz et al. | Studies on herpes simplex virus: II. A soluble antigen of herpes virus possessing skin-reactive properties | |
| RU2603003C1 (ru) | Вакцина инактивированная сорбированная против ящура типов а, о, азия-1 | |
| Redman et al. | Comparison of IgM and IgG anti-A and anti-B levels in Asian, Caucasian and Negro donors in the North West Thames Region | |
| Bell | An introduction to general virology | |
| RU2699671C1 (ru) | Вакцина для ранней защиты против ящура типа О инактивированная эмульсионная | |
| Kono et al. | An epidemic of Getah virus infection among racehorses: properties of the virus | |
| Karim et al. | Sero-epidemiology ofhepatitis A in black South African children | |
| Musser et al. | Measles virus growth in canine renal cell cultures | |
| Plotkin et al. | Persistence of antibodies after vaccination with living attenuated poliovirus | |
| RU2682876C1 (ru) | Вакцина инактивированная эмульсионная против ящура типа О | |
| Kroon et al. | Abortive and subclinical poliomyelitis in a family during the 1992 epidemic in The Netherlands | |
| CN104402995A (zh) | 抗流感病毒鸡卵黄抗体的制备方法及应用 | |
| RU2817031C1 (ru) | Штамм "О N 2222/Тайвань/1/2012" вируса ящура Aphtae epizooticae для изготовления биопрепаратов для диагностики и специфической профилактики ящура | |
| RU2816943C1 (ru) | Штамм "Азия-1/G-V/2006" вируса ящура Aphtae epizooticae генотипа Азия-1/G-V для изготовления биопрепаратов для диагностики и специфической профилактики ящура | |
| Middleton Jr et al. | Micro diffusion precipitin tests for enteroviruses and influenza B virus | |
| Trivello et al. | Immunity status to poliovirus in Veneto region (north-east Italy). A seroepidemiological survey | |
| RU2322503C1 (ru) | Способ получения высокоспецифичной гетерологичной антирабической сыворотки | |
| Smith et al. | Serologic evidence that infectious canine hepatitis virus commonly infects humans and is related to human adenovirus type 8 | |
| FUJITA | RESEARCH ON DENGUE IN TISSUE CULTURE: IV. Serologic Responses of Human Beings to Combined Inoculations of Attenuated, Tissue-Cultured Type I Dengue Virus and Yellow Fever Vaccine | |
| Wardley et al. | A blastogenic test for foot-and-mouth disease |